Assessment of comorbidity in lung cancer: How, why, and in whom?
Author:
- 3 March 2016
- journal article
- editorial
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 7 (2) , 64-67
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Comorbidity and survival of Danish lung cancer patients from 2000–2011: a population-based cohort studyClinical Epidemiology, 2013
- Predictive Ability of Charlson Comorbidity Index on Outcomes From Lung CancerAmerican Journal of Clinical Oncology, 2011
- Prognostic impact of comorbidity in elderly lung cancer patients: Use and comparison of two scoresLung Cancer, 2011
- Impact of comorbidities on clinical outcomes in non-small cell lung cancer patients who are elderly and/or have poor performance statusCritical Reviews in Oncology/Hematology, 2010
- Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapyEuropean Journal of Cancer, 2010
- Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patientsAnnals of Oncology, 2008
- Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results DatabaseJournal of Clinical Oncology, 2007
- Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly StudyJournal of Clinical Oncology, 2005
- Impact of comorbidity on lung cancer survivalInternational Journal of Cancer, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987